Clinical Trials Directory

Trials / Completed

CompletedNCT01853696

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty

Prospective, Randomized Comparison of Corticosteroid Dosing Regimens Following Endothelial Keratoplasty

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
167 (actual)
Sponsor
Cornea Research Foundation of America · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Graft rejection has traditionally been one of the leading causes of cornea transplant failure. To help prevent rejection, corticosteroid eye drops are used for an extended period after transplant surgery. The purpose of this study is to compare the efficacy and side effects of different corticosteroid dosing regimens after endothelial keratoplasty (cornea transplant) surgery.

Conditions

Interventions

TypeNameDescription
DRUGloteprednol etabonate
DRUGprednisolone acetate 1%

Timeline

Start date
2013-03-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2013-05-15
Last updated
2015-05-15
Results posted
2015-04-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01853696. Inclusion in this directory is not an endorsement.

Comparison of Corticosteroid Dosing Regimens After Endothelial Keratoplasty (NCT01853696) · Clinical Trials Directory